...
机译:在ERK5中发现新型变构抑制剂结合位点:与规范激酶铰链ATP结合位点的比较
AstraZeneca R&
D Discovery Sci Chem Innovat Ctr S-43183 Molndal Sweden;
AstraZeneca R&
D Discovery Sci Struct &
Biophys Alderley Pk Macclesfield SK10 4TG Cheshire England;
AstraZeneca Asia &
Emerging Markets iMed Innovat Ctr China Shanghai 201203 Peoples R China;
AstraZeneca Asia &
Emerging Markets iMed Innovat Ctr China Shanghai 201203 Peoples R China;
AstraZeneca R&
D Discovery Sci Struct &
Biophys Alderley Pk Macclesfield SK10 4TG Cheshire England;
Proteros Biostruct GmbH Bunsenstr 7A D-82152 Martinsried Germany;
Proteros Biostruct GmbH Bunsenstr 7A D-82152 Martinsried Germany;
Proteros Biostruct GmbH Bunsenstr 7A D-82152 Martinsried Germany;
AstraZeneca R&
D Discovery Sci Screening Sci Alderley Pk Macclesfield SK10 4TG Cheshire England;
AstraZeneca R&
D Discovery Sci Struct &
Biophys Alderley Pk Macclesfield SK10 4TG Cheshire England;
ERK5 kinase; allosteric kinase inhibitor; MAPK7 kinase; crystal structure;
机译:在ERK5中发现新型变构抑制剂结合位点:与规范激酶铰链ATP结合位点的比较
机译:19 sup>基于F-NMR的双现场报告器测定,用于发现和区分催化和颠氨激酶抑制剂
机译:基于分子支架的设计和组合文库的比较侧重于蛋白激酶的ATP结合位点
机译:一种通过改变激酶识别位点重编程荷尔蒙信号传导的人基因多态性:鉴定SNP产生的磷酸化位点
机译:定点配体的变构位点和蛋白质-蛋白质界面的发现
机译:在ERK5中发现一个新的变构抑制剂结合位点:与规范激酶铰链ATP结合位点的比较
机译:ERK5中新型变构抑制剂结合位点的发现:与规范激酶铰链ATP结合位点的比较
机译:腺病毒蛋白酶 - 抗病毒靶标,用于单一酶的三联疗法:潜在的抑制剂结合位点